68 related articles for article (PubMed ID: 25636480)
1. Methods to study primary tumor cells and residual tumor cells in mouse models of oncogene dependence.
Botta C; Darini C; Darrasse-Jèze G; Podsypanina K
Methods Mol Biol; 2015; 1267():381-94. PubMed ID: 25636480
[TBL] [Abstract][Full Text] [Related]
2. Leaving home early: reexamination of the canonical models of tumor progression.
Weinberg RA
Cancer Cell; 2008 Oct; 14(4):283-4. PubMed ID: 18835030
[TBL] [Abstract][Full Text] [Related]
3. Harvey-ras mediated neoplastic development in the mouse mammary gland.
Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
5. Oncogene expression in mammary epithelial cells.
Groner B
J Cell Biochem; 1992 Jun; 49(2):128-36. PubMed ID: 1400620
[TBL] [Abstract][Full Text] [Related]
6. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
7. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
8. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland.
Bradbury JM; Arno J; Edwards PA
Oncogene; 1993 Jun; 8(6):1551-8. PubMed ID: 8099220
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mouse models of mammary tumorigenesis.
Cardiff RD; Muller WJ
Cancer Surv; 1993; 16():97-113. PubMed ID: 8394206
[No Abstract] [Full Text] [Related]
11. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
12. Mammary tumorigenesis and metastasis in transgenic mice.
Webster MA; Muller WJ
Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
Amundadottir LT; Leder P
Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
[TBL] [Abstract][Full Text] [Related]
14. Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glands.
Roth DR; Roman D; Cozens R; Brandt R; Seewald W; Greiner B; Wenger F; Mamom T; Germann PG
Exp Toxicol Pathol; 2003 Nov; 55(4):237-45. PubMed ID: 14703768
[TBL] [Abstract][Full Text] [Related]
15. Loss of a negative feedback loop involving pea3 and cyclin d2 is required for pea3-induced migration in transformed mammary epithelial cells.
Ladam F; Damour I; Dumont P; Kherrouche Z; de Launoit Y; Tulasne D; Chotteau-Lelievre A
Mol Cancer Res; 2013 Nov; 11(11):1412-24. PubMed ID: 23989931
[TBL] [Abstract][Full Text] [Related]
16. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
17. Expression of the retrotransposons, intracisternal A-particles, during neoplastic progression of mouse mammary epithelium analyzed with a monoclonal antibody.
Asch BB; Asch HL
Cancer Res; 1990 Apr; 50(8):2404-10. PubMed ID: 2156618
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice.
Elson A
Oncogene; 1999 Dec; 18(52):7535-42. PubMed ID: 10602512
[TBL] [Abstract][Full Text] [Related]
19. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
Medina D; Kittrell FS; Oborn CJ; Schwartz M
Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
Kitsberg DI; Leder P
Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
